Commentary: Neonatal applications of cardiac cell therapy: It's good to be young!
- PMID: 33097214
- PMCID: PMC8024413
- DOI: 10.1016/j.jtcvs.2020.09.107
Commentary: Neonatal applications of cardiac cell therapy: It's good to be young!
Conflict of interest statement
Disclosures: The authors reported no conflicts of interest.
Comment on
-
Cardiac stem cell therapy: Does a newborn infant's heart have infinite potential for stem cell therapy?J Thorac Cardiovasc Surg. 2022 Jan;163(1):242-247. doi: 10.1016/j.jtcvs.2020.07.124. Epub 2020 Sep 14. J Thorac Cardiovasc Surg. 2022. PMID: 33070938 No abstract available.
References
-
- Gyöngyösi M, Haller PM, Blake DJ, Martin Rendon E. Meta-analysis of cell therapy studies in heart failure and acute myocardial infarction. Circ Res. 2018;123: 301–8. - PubMed
-
- Epstein JA. A time to press reset and regenerate cardiac stem cell biology. JAMA Cardiol. 2019;4:95. - PubMed
-
- Sano S, Sano T, Ishigami S, Ito T. Cardiac stem cell therapy—has newborn heart an infinite potential for stem cell therapy? J Thorac Cardiovasc Surg. 2020. [In press]. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
